Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Headache|February 12, 2005
Migraine, botulinum toxin type-A, and the disappearing sebaceous cystIra M Turner, Tiffany AgrilloHeadache|June 19, 2013
A cross-sectional survey to assess the migraineur's medication decision-making beliefs: determining when a migraine is triptan-worthyStephen H Landy, Ira M Turner, M Chris Runken, et al.Preventing Chronic Disease|December 22, 2018
Transitions From Heart Disease to Cancer as the Leading Cause of Death in US States, 1999-2016Michael C Harding, Chantel D Sloan, Ray M Merrill, et al.Journal of Primary Care & Community Health|September 28, 2020
Patient-Reported Outcomes from a 1-Year, Real-World, Head-to-Head Comparison of OnabotulinumtoxinA and Topiramate for Headache Prevention in Adults With Chronic MigraineAndrew M Blumenfeld, Atul T Patel, Ira M Turner, et al.BMC Neurology|August 15, 2019
Effect of a rescue or recurrence dose of lasmiditan on efficacy and safety in the acute treatment of migraine: findings from the phase 3 trials (SAMURAI and SPARTAN)Li Shen Loo, Brian M Plato, Ira M Turner, et al.Headache|May 20, 2011
Multi-center comparison of response to a single tablet of sumatriptan 85 mg and naproxen 500 mg vs usual therapy treating multiple migraine attacks as measured by the completeness of response surveyRoger Cady, Jim Banks, Robert B Nett, et al.Journal of the Neurological Sciences|June 25, 2013
OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baselineStephen D Silberstein, Andrew M Blumenfeld, Roger K Cady, et al.Pageof 1